Wysham Douglas G MD Spokane, WA - 99204

Wysham Douglas G MD is categorized under Internal Medicine Practitioners in Spokane, WA and active since 2011.

Wysham Douglas G MD was established in 2011, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Internal Medicine Practitioners business, which does work in the B2C market, and is classified as a Internal Medicine Practitioners, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Douglas Wysham at the company’s single location by writing to 910 West 5th Avenue # 700, Spokane, Washington WA 99204 or by phoning (509) 838-2531. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Wysham Douglas G MD
Contact Person: Douglas Wysham
Address: 910 West 5th Avenue # 700, Spokane, Washington 99204
Phone Number: (509) 838-2531
Website Address: rockwoodclinic.com
Annual Revenue (USD): $500.000 to $999.999
Founded: 2011
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Internal Medicine Practitioners
SIC Code: 8011
NAICS Code: 6211110
Share This Business:

Wysham Douglas G MD was started in 2011 to provide professional Internal Medicine Practitioners under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.

Feel free to contact Douglas Wysham for inquiries that concern Wysham Douglas G MD by calling the company number (509) 838-2531, as your correspondence is most welcome. Additionally, the physical location of the single location of Wysham Douglas G MD can be found at the coordinates 47.651448,-117.425131 as well as the street address 910 West 5th Avenue # 700 in Spokane, Washington 99204.

For its online presence, you may visit Wysham Douglas G MD’s website at rockwoodclinic.com and engage with its social media outlets through on Twitter and on Facebook.